Could a common supplement protect eyes in diabetes?
NCT ID NCT07634991
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether N-acetyl cysteine (NAC), a safe supplement, can reduce oxidative stress and improve eye health in people with type 2 diabetes who have mild to moderate diabetic retinopathy. About 76 adults aged 18-70 will take NAC to see if it lowers damage to blood vessels in the eye. The goal is to slow or control the disease, not cure it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institute of Diabetes and Endocrinology.
RECRUITINGCairo, Egypt
-
National Institute of Diabetes and Endocrinology.
RECRUITINGCairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI eye doctor: could software catch diabetic blindness sooner?
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Can eye scans reveal hidden clues about diabetes damage?
- Can tight blood sugar control protect the eyes? a study uses advanced imaging to find out
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?